Pelizaeus-Merzbacher disease in patients with molecularly confirmed diagnosis

by Hanna Mierzewska, Ewa Jamroz, Tomasz Mazurczak, Dorota Hoffman-Zacharska, Elżbieta Szczepanik
Published 2016-03-01

Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.

by Teresa Joanna Stradomska, Małgorzata Syczewska, Ewa Jamroz, Agata Pleskaczyńska, Piotr Kruczek, Elżbieta Ciara, Anna Tylki-Szymanska
Published 2020-01-01

NMR-based metabolomics in pediatric drug resistant epilepsy – preliminary results

by Łukasz Boguszewicz, Ewa Jamroz, Mateusz Ciszek, Ewa Emich-Widera, Marek Kijonka, Tomasz Banasik, Agnieszka Skorupa, Maria Sokół
Published 2019-10-01

Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II

by Miroslaw Bik-Multanowski, Ewa Jamroz, Lukasz Kaluzny, Ewa Pronicka, Dariusz Rokicki, Ewa Starostecka, Jolanta Sykut-Cegielska, Mieczyslaw Walczak
Published 2016-03-01

Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders

by Teresa Joanna Stradomska, Małgorzata Syczewska, Ewa Jamroz, Agata Pleskaczyńska, Piotr Kruczek, Elżbieta Ciara, Anna Tylki-Szymanska, Metodi D Metodiev
Published 2020-01-01

The First Metabolome Analysis in Children with Epilepsy and ALG13-CDG Resulting from c.320A>G Variant

by Justyna Paprocka, Aleksandra Jezela-Stanek, Łukasz Boguszewicz, Maria Sokół, Patryk Lipiński, Ewa Jamroz, Ewa Emich-Widera, Anna Tylki-Szymańska
Published 2021-03-01